Adelaide BioMed City is one of the largest health and life science clusters in the Southern Hemisphere. It brings together research, education, clinical care and business development.
The precinct includes the iconic South Australian Health and Medical Research Institute (SAHMRI) building , the new Royal Adelaide Hospital, University of South Australia’s Health Innovation Building including the Centre for Cancer Biology and University of Adelaide’s Health and Medical Sciences Building .
The new 800-bed Royal Adelaide Hospital will receive more than 80,000 admissions a year and employ more than 6,000 staff. The building itself has been specifically designed to create a healing environment for patients, a positive working environment for staff, and to have minimal environmental impact. It will remain a major teaching hospital.
The SAHMRI building, opened in November 2013, is a centre of scientific research for 600 researchers, including teams from the CSIRO and the state’s three universities. The facility delivers a world-class research facility designed specifically to foster innovation and improvements in health services. The striking building wrapped in a glass façade is already a prominent part of the North Terrace streetscape.
SAHMRI 2 will house over 500 researchers across 12 floors and be the site of Australia’s first proton therapy unit. The technology delivers cancer destroying protons to the tumour site of otherwise inoperable cancers without affecting healthy tissues.
Adelaide BioMed City maintains a strong relationship with the Technology Precinct in neighbouring Thebarton. This precinct is home to BioInnovation SA and features Australia’s first dedicated bioscience incubator, launched in 2008 to accelerate the commercialisation of research and development in South Australia.